Dihydroartemisinin-cyclodextrin complexation: Solubility and stability

Archives of Pharmacal Research

Volumn 32, Issue 1, 2009, Pages 155-165

  Ansari, Muhammad Tayyab ^a   Iqbal, Ijaz ^a   Sunderland, Vivian Bruce ^b  

^a BAHAUDDIN ZAKARIYA UNIVERSITY   (Pakistan)

^b CURTIN UNIVERSITY   (Australia)

Author keywords

Dihydroartemisinin; HP CD; Hydroxypropyl cyclodextrin; Phase solubility; Thermal stability

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ACETIC ACID; BUFFER; CYCLODEXTRIN; DIHYDROARTEMISININ; PHOSPHATE; WATER;

ARTICLE; COMPLEX FORMATION; CONCENTRATION RESPONSE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DEGRADATION; DRUG HYDROLYSIS; DRUG SOLUBILITY; DRUG STABILITY; DRUG SYNTHESIS; HYDROGEN BOND; INFRARED SPECTROSCOPY; PH; PHASE TRANSITION; STOICHIOMETRY; THERMOSTABILITY; X RAY DIFFRACTION;

ADMINISTRATION, ORAL; ANTIMALARIALS; ARTEMISININS; BETA-CYCLODEXTRINS; BUFFERS; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CRYSTALLOGRAPHY, X-RAY; DRUG STABILITY; HYDROGEN BONDING; HYDROGEN-ION CONCENTRATION; HYDROLYSIS; INJECTIONS, INTRAVENOUS; MODELS, CHEMICAL; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TECHNOLOGY, PHARMACEUTICAL; TEMPERATURE;

EID: 59449094181     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-009-1130-4     Document Type: Article

References (37)

1. M. M. Al Omari M. B. Zughul J. E. D. Davies A. A. Badwan 2006 effect of buffer species on the inclusion complexation of acidic drug celecoxib with cyclodextrin in solution J. Inclu. Phen. Macrocy. Chem. 55 247 254
2. M. T. Ansari V. B. Sunderland 2008 Solid dispersions of dihydroartemisinin in polyvinylpyrrolidone Arch. of Pharm. Res. 31 3 390 398
3. Baboota, S., Khanna, R., Agarwal, S. P., Ali, J., and Ahuja, A., Cyclodextrins in drug delivery systems: An update. PharmaInfo. net. (2003).
4. T. Backensfeld B. W. Muller K. Kolter 1991 Interaction of NSA with cyclodextrins and Hydroxypropyl cyclodextrin derivatives Int. J. Pharm. 74 85 93
5. H. Cabral Marques J. Hadgraft I. Kllaway 1990 Studies of cyclodextrin inclusion complexes. 1. The salbutamol-cylodex trin complex as studied by phase solubility and DSC Int. J. Pharm. 63 259 266
6. X. Chen R. Chen Z. Guo C. Li P. Li 2007 The preparation and stability of the inclusion complex of astaxanthin with β-cyclodextrin Food, Chem. 101 1580 1584
7. M. Cirri F. Maestrelli G. Corti S. Furlanetto P. Mura 2006 Simultaneous effect of cyclodextrins complexation, pH and hydrophilic polymers on naproxen solubilization J. Pharm. BioMed Anal. 42 126 131
8. D. R. de Araujo S. S. Tsuneda C. M. S. Cereda F. D. G. F. Carvalho P. S. C. Prete S. A. Fernandes F. Yokaichiya M. K. K. D. Franco I. Mazzaro L. F. Fraceto A. F. A. Braga E. Paula 2008 Development of pharmacological evaluation of ropivacaine-2-hydroxypropyl-β-cyclodextrin inclusion complexes Eur. J. Pharm. Sci. 33 60 71
9. P. J. de Vries T. K. Dien 1996 Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria Drugs 52 6 818 836
10. S. K. Dordunoo H. M. Burt 1996 Solubility and stability of taxol: effects of buffers and cyclodextrins Int. J. Pharm. 133 191 201
11. E. Elisabeth 2006 The history of qing hao in the Chinese materia medica Trans. Roy. Soc. Trop. Med. Hyg. 100 505 508
12. C. M. Fernandes M. T. Vieira F. J. Veiga 2002 Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds Eur. J. Pharm. Sci. 15 79 88
13. T. Higuchi K. A. Connors 1965 Phase solubility technique Adv. Anal. Chem. Instrum. 4 117 212
14. A. C. Illapakurthy Y. A. Sabnis B. A. Avery M. A. Avery C. M. Wyandt 2003 Interaction of artemisinin and its related compounds with Hydroxypropyl-β- cyclodextrin in solution state: Experimental and Molecular-Modeling studies J. Pharm. Sci. 92 649 655
15. J. Kang V. Kumar D. Yang P. R. Chowdhary R. J. Hohl 2002 Cyclodextrin complexation: influence on the solubility, and cytotoxicity of camptothecin, an antineoplastic agent Eur. J. Pharm. Sci. 15 163 170
16. Q. C. Li J. O. Peggins L. L. Fleckenstein K. Masonic M. H. Heiffer T. G. Brewer 1998 The pharmacokinetics and bioavailability of dihydroartemisinin, arteether, artemether, artesunic acid and artelinic acid in rats J. Pharm. Pharmacol. 50 173 182
17. X. Liu H. Lin I. C. Thenmozhiyal S. Y. Chan P. C. Ho 2003 Inclusion of Acitretin into cyclodextrins: Phase solubility, photostability, and physicochemical characterization J. Pharm. Sci. 92 12 2449 2457
18. T. Loftsson D. Duchene 2007 Cyclodextrins and their pharmaceutical applications Int. J. Pharm. 329 1 11
19. T. Loftsson M. Brewster 1996 Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization J. Pharm. Sci. 85 10 1017 1025
20. K. Miyake T. Irie H. Arima F. Hirayama K. Uekama M. Hirano Y. Okamoto 1999 Characterization of itroconazole/2-hydroxypropyl-β-cyclodextrin inclusion complex in aqueous propylene glycol solution Int. J. Pharm. 179 2 237 245
21. K. Mochida A. Kagita Y. Matsui Y. Date 1973 Effects of Inorganic Salts on the Dissociation of a Complex of β-Cyclodextrin with an Azo Dye in an Aqueous Solution Bull. Chem. Soc. Japn. 46 3703 3707
22. Monographs for antimalarial drugs. In. International Pharmacopoeia, 215 (2004).
23. M. S. Nagarsenker M. S. Joshi 2005 Celecoxib-cyclodextrin systems: Characterization and evaluation of In vitro and In vivo advantage Drug Dev. Ind. Pharm. 31 169 178
24. Passmore, P. and Sunderland, V. B., Quality assurance in formulation development and analytical methods for combination antimalarial products. A report of School of Pharmacy, Curtin University of Technology, Australia (2003).
25. J. Peeters P. Neeskens J. P. Tollenaere P. V. Remoortere M. E. Brewster 2002 Characterization of the interaction of 2-hydroxypropyl-β-cyclodextrin with iteraconazole at pH 2,4, and 7 J. Pharm. Sci. 91 6 1414 1422
26. G. L. Perlovich M. Skar A. Bauer-Brandl 2003 Driving forces and the influence of the buffer composition on the complexation reaction between ibuprofen and HPβCD Eur. J. Pharm. Sci. 20 197 200
27. Pogany, D., "Stability. In. Prequalification of antimalarial drug products. Geneva. 21-22 (2004).
28. R. A. Rajewski G. Traiger J. Bresnahan P. Jaberaboansari V. J. Stella D. O. Thompson 1995 Preliminary safety evaluation of parenterally administered sulfoalkyl ether β-cyclodextrin derivatives J. Pharm. Sci. 84 927 932
29. S. Rawat S. K. Jain 2004 Solubility enhancement of celecoxib using β-cyclodextrin inclusion complexes Eur. J. Pharm. Biopharm. 57 263 267
30. M. N. Reddy T. Rehana S. Ramakrishna P. V. Diwan K. P. R. Chowdary 2004 Beta-cyclodextrin complexes of celecoxib: molecular-modeling characterization and dissolution studies AAPS Pharm. Sci. 6 7 13
31. S. Sethia E. Squillante 2004 Solid dispersion of carbamazepine in PVP by conventional solvent evaporation and supercritical methods Int. J. Pharm. 272 1 10
32. V. J. Stella R. A. Rajewski 1997 Cyclodextrins: their future in drug formulation and delivery Pharm. Res. 14 556 567
33. S. Tommasini M. L. Calabro D. Raneri P. Ficarra R. Ficarra 2004 Solubilization of non-steroidal anti-inflammatory J. Pharm. Biomed. Anal. 36 327 333
34. M. Usuda T. Endo H. Nagase K. Tomono H. Ueda 2000 Interaction of antimalarial agent artemisinin with cyclodextrins Drug Dev. Ind. Pharm. 26 6 613 619
35. J. F. Wojcik R. P. Rohrbach 1975 Small anion binding to cycloamylose. Equilibrium constants J. Phys. Chem. 79 21 2251 2253
36. Z. Yi C. Zhao Z. Huang H. Chen J. Yu 1999 investigation of buffer cyclodextrin systems Phys. Chem. Chem. Phys. 1 441 448
37. G. Zingone F. Rubessa 2005 Preformulation study of the inclusion complex warfarin-β-cyclodextrin Int. J. Pharm. 291 3 10